People: Osiris Therapeutics Inc (OSIR.OQ)

OSIR.OQ on NASDAQ Stock Exchange Global Market

19.35USD
11:17am EDT
Change (% chg)

$-0.17 (-0.87%)
Prev Close
$19.52
Open
$19.52
Day's High
$19.53
Day's Low
$19.35
Volume
13,274
Avg. Vol
45,441
52-wk High
$20.70
52-wk Low
$11.87

Search Stocks

Debrabandere, Lode 

Dr. Lode Debrabandere, Ph.D., is President, Chief Executive Officer, Director of Osiris Therapeutics, Inc. Prior to joining Osiris, Dr. Debrabandere served for over four years with Bristol-Myers Squibb as Vice President for Strategic Marketing for Neuroscience and Infectious Diseases. He joined us in July 2006 as our Vice President and General Manager of Therapeutics. He became our Chief Operating Officer in October 2012, and was elected to our Board of Directors in January 2014. Dr. Debrabandere has over 20-years of experience leading R&D and sales and marketing activities in the pharmaceutical and biotechnology industries. Prior to joining us, he served as Vice President of Global Marketing of Bristol Myers Squibb where he led the Neuroscience Unit and was the Global Brand Manager for Abilify™. He currently serves on the Board of Directors of Prolexys Pharmaceuticals, Inc. His leadership and management experience, as well as his day-to-day service as Chief Executive Officer and technical expertise, make him a valued member of the Osiris board.

Basic Compensation

Total Annual Compensation, USD 510,000
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 1,195,500
Fiscal Year Total, USD 1,705,500

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Peter Friedli

--

Lode Debrabandere

1,705,500

Philip Jacoby

244,329

Gregory Law

162,405

Frank Czworka

569,725

Adrian Mollo

--
As Of  30 Dec 2014
Search Stocks